Nasdaq · CIK 0001005286
LFCR LIFECORE BIOMEDICAL, INC. \DE\
Insider trading from SEC Form 4. Last filing Sep 4, 2025. Close $6.45 on Oct 9, 2026, +76% from the 52-week low and -27% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
LFCROct 9, 2026 · close 6.45
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at LIFECORE BIOMEDICAL, INC. \DE\, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | Aron R. English owner sell | $9.1M 1,386,060 shares | -84% | +50% from low-13% from high | |
| 21Weak | Aron R. English owner sell | $86k 12,334 shares | -1% | +55% from low-10% from high | |
| 27Weak | Aron R. English owner sell | $362k 51,496 shares | -3% | +53% from low-11% from high | |
| 26Weak | Aron R. English owner sell | $290k 41,091 shares | -2% | +56% from low-10% from high | |
| 35Weak | Paul Josephs Chief Executive Officer buy | $98k 17,000 shares | +3% | - |
Transactions
The last 40 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Ryan David Lake Chief Financial Officer | FTax withholding Common Stock | -22,932 | $7.71 | $177k | 336,691 | Sep 4, 2025 |
| Jul 15, 2025 | Humberto Calheiros Antunes director | AGrant or award Common Stock | +19,506 | - | - | 47,060 | Jul 17, 2025 |
| Jul 15, 2025 | Nelson Obus director | AGrant or award Common Stock | +19,506 | - | - | 138,193 | Jul 17, 2025 |
| Jul 15, 2025 | Joshua Schechter director | AGrant or award Common Stock | +19,506 | - | - | 107,173 | Jul 17, 2025 |
| Jul 15, 2025 | Matthew E Korenberg director | AGrant or award Common Stock | +19,506 | - | - | 44,060 | Jul 17, 2025 |
| Jul 15, 2025 | Christopher S Kiper director, owner | AGrant or award Common Stock | +19,506 | - | - | 77,575 | Jul 17, 2025 |
| Jul 15, 2025 | Paul Harold Johnson director | AGrant or award Common Stock | +19,506 | - | - | 44,060 | Jul 17, 2025 |
| Jul 15, 2025 | Lovas Katrina Houde director | AGrant or award Common Stock | +19,506 | - | - | 109,412 | Jul 17, 2025 |
| Jul 15, 2025 | Jason Aryeh director | AGrant or award Common Stock | +19,506 | - | - | 44,060 | Jul 17, 2025 |
| Jul 8, 2025 | Paul Josephs Chief Executive Officer | MOption exercise Common Stock | +150,000 | - | - | 688,185 | Jul 10, 2025 |
| Jul 8, 2025 | Ryan David Lake Chief Financial Officer | MOption exercise Common Stock | +75,000 | - | - | 392,429 | Jul 10, 2025 |
| Jul 8, 2025 | Thomas D. Salus Chief Legal & Administration | MOption exercise Common Stock | +37,000 | - | - | 252,000 | Jul 10, 2025 |
| Jul 8, 2025 | Paul Josephs Chief Executive Officer | FTax withholding Common Stock | -54,857 | $8.19 | $449k | 633,328 | Jul 10, 2025 |
| Jul 8, 2025 | Ryan David Lake Chief Financial Officer | FTax withholding Common Stock | -32,806 | $8.19 | $269k | 359,623 | Jul 10, 2025 |
| Jul 8, 2025 | Thomas D. Salus Chief Legal & Administration | FTax withholding Common Stock | -11,022 | $8.19 | $90k | 240,978 | Jul 10, 2025 |
| Jul 8, 2025 | Paul Josephs Chief Executive Officer | MOption exercise Performance-Based Restricted Stock Unitsderivative | -150,000 | - | - | 1,350,000 | Jul 10, 2025 |
| Jul 8, 2025 | Ryan David Lake Chief Financial Officer | MOption exercise Performance-Based Restricted Stock Unitsderivative | -75,000 | - | - | 600,000 | Jul 10, 2025 |
| Jul 8, 2025 | Thomas D. Salus Chief Legal & Administration | MOption exercise Performance-Based Restricted Stock Unitsderivative | -37,000 | - | - | 333,000 | Jul 10, 2025 |
| May 23, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -96,137 | $6.75 | $649k | 1,554,103 | May 28, 2025 |
| May 27, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -1,139,504 | $6.50 | $7.4M | 414,599 | May 28, 2025 |
| May 28, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -150,419 | $7.12 | $1.1M | 264,180 | May 28, 2025 |
| May 20, 2025 | Paul Josephs Chief Executive Officer | FTax withholding Common Stock | -21,532 | $6.63 | $143k | 538,185 | May 22, 2025 |
| May 13, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -12,334 | $7.00 | $86k | 1,650,240 | May 16, 2025 |
| May 8, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -5,098 | $7.00 | $36k | 1,708,972 | May 12, 2025 |
| May 9, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -700 | $7.00 | $4,900 | 1,708,272 | May 12, 2025 |
| May 12, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -45,698 | $7.03 | $321k | 1,662,574 | May 12, 2025 |
| May 5, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -24,543 | $7.08 | $174k | 1,730,618 | May 7, 2025 |
| May 6, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -701 | $7.05 | $4,940 | 1,729,917 | May 7, 2025 |
| May 7, 2025 | Aron R. English owner | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -15,847 | $7.01 | $111k | 1,714,070 | May 7, 2025 |
| Apr 14, 2025 | Thomas D. Salus Chief Legal & Administration | AGrant or award Common Stock | +45,000 | - | - | 45,000 | Apr 16, 2025 |
| Apr 14, 2025 | Thomas D. Salus Chief Legal & Administration | AGrant or award Common Stock | +170,000 | - | - | 215,000 | Apr 16, 2025 |
| Apr 14, 2025 | Thomas D. Salus Chief Legal & Administration | AGrant or award Performance-Based Restricted Stock Unitsderivative | +370,000 | $0.00 | $0 | 0 | Apr 16, 2025 |
| Apr 14, 2025 | Thomas D. Salus Chief Legal & Administration | AGrant or award Incentive Stock Option (Right to Buy)derivative | +210,000 | $0.00 | $0 | 210,000 | Apr 16, 2025 |
| Jan 8, 2025 | Paul Josephs Chief Executive Officer | POpen-market purchase Common Stock | +17,000 | $5.74 | $98k | 559,717 | Jan 8, 2025 |
| Dec 6, 2024 | Paul Josephs Chief Executive Officer | AGrant or award Common Stock | +38,461 | $0.00 | $0 | 554,486 | Dec 10, 2024 |
| Dec 6, 2024 | Ryan David Lake Chief Financial Officer | AGrant or award Common Stock | +19,720 | $0.00 | $0 | 323,082 | Dec 10, 2024 |
| Dec 6, 2024 | Paul Josephs Chief Executive Officer | FTax withholding Common Stock | -11,769 | $7.15 | $84k | 542,717 | Dec 10, 2024 |
| Dec 6, 2024 | Ryan David Lake Chief Financial Officer | FTax withholding Common Stock | -5,653 | $7.15 | $40k | 317,429 | Dec 10, 2024 |
| Oct 7, 2024 | Ryan David Lake Chief Financial Officer | MOption exercise Common Stock | +75,000 | - | - | 337,500 | Oct 29, 2024 |
| Oct 7, 2024 | Ryan David Lake Chief Financial Officer | FTax withholding Common Stock | -34,138 | $5.09 | $174k | 303,362 | Oct 29, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Humberto Calheiros Antunesdirector
- Jason Aryehdirector
- Aron R. Englishowner, director
- Lovas Katrina Houdedirector
- Paul Harold Johnsondirector
- Paul JosephsChief Executive Officer
- Christopher S Kiperdirector, owner
- Matthew E Korenbergcfo, officer, director
- Ryan David LakeChief Financial Officer
- Nelson Obusdirector
- Thomas D. SalusChief Legal & Administration
- Joshua Schechterdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.